France· FR:62955775
VELPHORO 500 mg, comprimé à croquer
A medicinal product containing oxyhydroxyde sucroferrique, registered in France by VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- OXYHYDROXYDE SUCROFERRIQUE
- Manufacturer
- VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400928022707flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 90 comprimé(s)EUR 152.28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Oxyhydroxyde sucroferrique in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainVelphoro 500 mg comprimidos masticablesVifor Fresenius Medical Care Renal Pharma France
- United KingdomVelphoro 500mg chewable tabletsVifor Fresenius Medical Care Renal Pharma UK Ltd
- BelgiumVelphoro 500 mgVifor Fresenius Medical Care Renal Pharma France
- NorwayVelphoroVifor Fresenius Medical Care Renal Pharma France (1)
- SwedenVelphoro 500 mg TuggtablettVifor Fresenius Medical Care Renal Pharma France
- United StatesVelphoroFresenius Medical Care Renal Therapies Group, LLC
- IcelandVelphoroVifor Fresenius Medical Care Renal Pharma France*
- Japanスクロオキシ水酸化鉄キッセイ薬品工業
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Velphoro
- Liechtenstein · Velphoro
- Norway · Velphoro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/261d620f-2461-40ac-aa52-5124016d0a72 GET /v1/drugs/261d620f-2461-40ac-aa52-5124016d0a72?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62955775",
"date_amm": "2014-08-26",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/943",
"substance": "OXYHYDROXYDE SUCROFERRIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé à croquer",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about oxyhydroxyde sucroferrique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.